FDA Inspection 745871 — OneBlood, Inc.

OneBlood, Inc. — FEI 1077496

The FDA completed an inspection of OneBlood, Inc. on Dec 19, 2011 in Fort Lauderdale, FL. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 10 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Dec 19, 2011
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fort Lauderdale, FL (United States)

Citations

IDCFRDescription
14221 CFR 606.140(a)Establishment of spec., standards, and test procedures
15421 CFR 606.160(a)(1)Concurrent documentation
15921 CFR 606.160(a)(1)Legibility and indelibility
16021 CFR 606.160(a)(1)Person performing, test results, interpretation
3121 CFR 606.20(b)Qualifications of responsible personnel
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
7821 CFR 606.100(c)Record review prior to release
922521 CFR 606.171Biological product deviation report
923421 CFR 630.40(c)Notification w/in 8 weeks
9821 CFR 606.100(c)Thorough investigations

Need the full FDA record for OneBlood, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.